ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,827Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 1000

$924K Total Retail Price of All Prescriptions

Rank: 64 out of 1000

435 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 435 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 435 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 11,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 834 580 1 2
HYDROCODONE-ACETAMINOPHEN 563 251 S3 2 1
GABAPENTIN 488 246 3 11
SIMVASTATIN 455 339 4 3
METFORMIN HCL 415 276 5 8
LEVOTHYROXINE SODIUM 377 275 6 4
FUROSEMIDE 359 251 7 7
POTASSIUM CHLORIDE 335 249 8 10
LISINOPRIL 329 197 9 5
CARVEDILOL 304 181 10 15
TRAMADOL HCL 278 145 11 13
LOVASTATIN 271 153 12 41
MELOXICAM 262 186 13 14
AMLODIPINE BESYLATE 257 187 14 6
DONEPEZIL HCL 250 199 15 32
METOPROLOL TARTRATE 250 189 15 19
ATORVASTATIN CALCIUM 243 112 17 18
VERAPAMIL ER 232 148 18 86
ENALAPRIL MALEATE 229 132 19 58
HYDROCHLOROTHIAZIDE 229 148 19 9
SERTRALINE HCL 222 166 21 26
FLUTICASONE PROPIONATE 213 105 22 40
NAMENDA 208 194 23 43
MIRTAZAPINE 203 147 24 56
GLIMEPIRIDE 199 127 25 34
TRIAMTERENE-HCTZ 198 158 26 48
METFORMIN HCL ER 195 109 27 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 187 140 28 20
CITALOPRAM HBR 172 113 29 17
TAMSULOSIN HCL 160 125 30 33
WARFARIN SODIUM 159 119 31 22
METHOCARBAMOL 158 87 R 32 79
ALLOPURINOL 157 110 33 31
PRAVASTATIN SODIUM 147 107 34 12
EXELON 145 145 35 108
FOSINOPRIL SODIUM 136 116 36 154
CLOPIDOGREL 136 108 36 35
SPIRIVA 134 90 38 64
FLUOXETINE HCL 124 76 39 51
NAPROXEN 124 82 39 81
ALENDRONATE SODIUM 123 113 41 57
RANITIDINE HCL 116 60 42 37
NEXIUM 113 57 43 23
CRESTOR 105 77 44 30
METOPROLOL SUCCINATE 104 74 45 21
AMITRIPTYLINE HCL 100 49 R 46 45
LOSARTAN POTASSIUM 99 77 47 25
TRAZODONE HCL 98 66 48 29
ISOSORBIDE MONONITRATE ER 98 75 48 71
ZOLPIDEM TARTRATE 94 47 50 16
FAMOTIDINE 94 53 50 88
PAROXETINE HCL 94 25 50 63
MEGESTROL ACETATE 92 83 R 53 134
PLAVIX 92 76 53 49
PANTOPRAZOLE SODIUM 91 73 55 28
AMOXICILLIN 91 62 55 89
LOSARTAN-HYDROCHLOROTHIAZIDE 90 72 57 38
GEMFIBROZIL 89 44 58 105
PROAIR HFA 87 48 59 50
QUETIAPINE FUMARATE 85 74 60 75
ESCITALOPRAM OXALATE 82 64 61 60
TRAMADOL HCL-ACETAMINOPHEN 82 68 61 151
CLONIDINE HCL 78 45 63 27
DIGOXIN 76 53 64 52
PREMARIN 75 30 R 65 109
DIOVAN 70 48 66 67
FENOFIBRATE 69 31 67 55
CYMBALTA 65 13 68 53
VENTOLIN HFA 65 34 68 83
LYRICA 64 0 70 47
ACTOS 63 39 71 119
CIPROFLOXACIN HCL 63 48 71 46
AZITHROMYCIN 61 34 73 36
SYNTHROID 61 42 73 91
PEN NEEDLE 60 22 75 165
ATENOLOL 59 40 76 24
TERAZOSIN HCL 56 39 77 150
DIVALPROEX SODIUM 54 44 78 113
SINGULAIR 54 22 78 84
DICLOFENAC SODIUM 52 19 80 123
RAMIPRIL 52 52 80 77
VERAPAMIL HCL 51 51 82 363
POLYETHYLENE GLYCOL 3350 51 27 82 69
CARBIDOPA-LEVODOPA 50 44 84 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.